107558-95-2

Upstream product

• 22621-41-6 2-hydroxy-3-nitro-benzoic acid methyl ester 
• 100-44-7 benzyl chloride 
• 85-38-1 3-nitrosalicylic acid 
• 100-39-0 benzyl bromide 

Downstream Products

• 847657-75-4 2-(benzyloxy)-3-nitro-N-[4-(4-phenylbutoxy)phenyl]benzamide 
• 1437872-91-7 2-(benzyloxy)-N-(3-(3-(2-(benzyloxy)phenylcarbamoyl)-2-methoxyphenylcarbamoyl)-2-methoxyphenyl)-3-nitrobenzamide 
• 1437872-93-9 2-(benzyloxy)-N-(2-(benzyloxy)-3-(3-(2-(benzyloxy)phenylcarbamoyl)-2-methoxyphenylcarbamoyl)phenyl)-3-nitrobenzamide 
• 1437872-85-9 2-(benzyloxy)-N-(3-(2-(benzyloxy)phenylcarbamoyl)-2-methoxyphenyl)-3-nitrobenzamide 
• 217095-90-4 tert-butyl (2-(benzyloxy)-3-nitrophenyl)carbamate 
• 213266-06-9 2-benzyloxy-3-nitro-benzoyl chloride 
• 1232692-30-6 methyl 3-(2-benzyloxy-3-nitrobenzamido)-2-methoxybenzoate 

Relevant academic research and scientific papers

CONDENSED RING COMPOUND AND USE THEREOF

The present invention relates to a compound of formula (I) (wherein all symbols have the same meanings as described hereinbefore). The compound antagonizes cysLT2 and therefore, it is useful as an agent for the prevention and/or treatment of respiratory diseases such as bronchial asthma, bronchial asthma, chronic obstructive pulmonary disease, pneumonectasia, chronic bronchitis, pneumonia (e.g. interstitial pneumonitis etc.), severe acute respiratory syndrome (SARS), acute respiratory distress syndrome (ARDS), allergic rhinitis, sinusitis (e.g. acute sinusitis, chronic sinusitis, etc.), and the like, or as an expectorant or antitussives.